# Phio Pharmaceuticals Corp.: Form 8-K, filed Nov 6, 2025

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2025-11-06
- Accepted by EDGAR: Nov 6, 2025, 21:11 ET
- Period: 2025-11-03
- Accession: 0001437749-25-033600
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000143774925033600/phio20251029_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000143774925033600/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000143774925033600/phio20251029_8k.htm

Filed Nov 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-033600. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.